RankingsPricing
  1. JP-listed companies
  2. RaQualia Pharma Inc.
  3. Financials
  4. Earnings per share

RaQualia Pharma Inc.【JP:4579】

Market cap
¥22.3B
P/E ratio
-313.5x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndEarnings per share (JPY)YoY (%)
Dec 31, 2024-22.9+52.67%
Dec 31, 2023-15-143.42%
Dec 31, 202234.5-4.35%
Dec 31, 202136.1-224.51%
Dec 31, 2020-29-11242.31%
Dec 31, 20190.3-100.48%
Dec 31, 2018-54.2+1713.71%
Dec 31, 2017-3-92.29%
Dec 31, 2016-38.8-66.68%
Dec 31, 2015-116.4+250.44%
Dec 31, 2014-33.2-60.83%
Dec 31, 2013-84.8-61.26%
Dec 31, 2012-219+26.70%
Dec 31, 2011-172.8

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)